PAVmed Research Development from 2010 to 2026

PAVM Stock  USD 10.10  0.53  5.54%   
PAVmed Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to grow to about 9.2 M this year. During the period from 2010 to 2026, PAVmed Research Development quarterly data regression pattern had sample variance of 56.9 T and median of  4,253,000. View All Fundamentals
 
Research Development  
First Reported
2014-06-30
Previous Quarter
790 K
Current Value
1.1 M
Quarterly Volatility
M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check PAVmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 907 K, Interest Expense of 49.2 K or Selling General Administrative of 15.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 2.4. PAVmed financial statements analysis is a perfect complement when working with PAVmed Valuation or Volatility modules.
  
Build AI portfolio with PAVmed Stock
Check out the analysis of PAVmed Correlation against competitors.
Evaluating PAVmed's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into PAVmed Inc's fundamental strength.

Latest PAVmed's Research Development Growth Pattern

Below is the plot of the Research Development of PAVmed Inc over the last few years. It is PAVmed's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

PAVmed Research Development Regression Statistics

Arithmetic Mean6,365,248
Geometric Mean1,145,237
Coefficient Of Variation118.46
Mean Deviation5,709,215
Median4,253,000
Standard Deviation7,540,586
Sample Variance56.9T
Range25.3M
R-Value0.67
Mean Square Error33.2T
R-Squared0.45
Significance0
Slope1,004,046
Total Sum of Squares909.8T

PAVmed Research Development History

20269.2 M
20256.8 M
20245.9 M
202314.3 M
202225.3 M
202119.8 M
202011 M

About PAVmed Financial Statements

PAVmed investors utilize fundamental indicators, such as Research Development, to predict how PAVmed Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development6.8 M9.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out the analysis of PAVmed Correlation against competitors.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could PAVmed diversify its offerings? Factors like these will boost the valuation of PAVmed. Anticipated expansion of PAVmed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PAVmed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.00)
Revenue Per Share
0.054
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.37)
Return On Equity
0.1744
Understanding PAVmed Inc requires distinguishing between market price and book value, where the latter reflects PAVmed's accounting equity. The concept of intrinsic value - what PAVmed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push PAVmed's price substantially above or below its fundamental value.
It's important to distinguish between PAVmed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PAVmed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, PAVmed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.